Sign in

CIK 0001478320 · Large accelerated filer

Adaptive Biotechnologies Corp

Sign in to watch
Ticker
ADPT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
WA
Entity type
operating
EIN
270907024
Phone
206-659-0067
Business address
1165 EASTLAKE AVE E, SEATTLE, WA, 98109
Former names
Adaptive TCR Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$33,491,115
in 20 filings, $14.5M under 10b5-1 plans

Net −$33,491,115. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. ROBINS CHAD M −$14.9M CEO and Chairman sold 22% of stake
  2. RUBINSTEIN JULIE −$10.2M President and COO sold 50% of stake
  3. LO FRANCIS −$4.0M Chief People Officer sold 39% of stake
  4. NEUPERT PETER M −$3.1M Director sold 49% of stake
  5. HERSHBERG ROBERT −$748K Director sold 40% of stake
Date Insider Transaction Shares Price Value Owned after
2021-01-25 RUBINSTEIN JULIE President Sale −1,813 $65.89 $119K 9,316
2021-01-25 RUBINSTEIN JULIE President Sale −8,816 $67.05 $591K 500
2021-01-25 RUBINSTEIN JULIE President Sale −500 $67.79 $34K 0
2021-01-25 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 155,000
2021-01-25 Cohen Chad M Chief Financial Officer Option exercise +50,000 $6.32 $316K 51,000
2021-01-25 Cohen Chad M Chief Financial Officer Sale −10,611 $65.08 $691K 40,389
2021-01-25 Cohen Chad M Chief Financial Officer Sale −20,953 $65.69 $1.4M 19,436
2021-01-25 Cohen Chad M Chief Financial Officer Sale −17,436 $67.03 $1.2M 2,000
2021-01-25 Cohen Chad M Chief Financial Officer Sale −1,000 $67.68 $68K 1,000
2021-01-25 Cohen Chad M Chief Financial Officer Option exercise · Stock Option (Right to Buy) −50,000 215,000
2021-01-22 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000
2021-01-22 RUBINSTEIN JULIE President Sale −5,524 $66.23 $366K 9,476
2021-01-22 RUBINSTEIN JULIE President Sale −9,476 $67.19 $637K 0
2021-01-22 RUBINSTEIN JULIE President Option exercise · Stock Option (Right to Buy) −15,000 170,000
2021-01-21 ROBINS HARLAN S Chief Scientific Officer Option exercise +23,370 $6.32 $148K 24,049
2021-01-21 ROBINS HARLAN S Chief Scientific Officer Sale −3,941 $66.06 $260K 20,108
2021-01-21 ROBINS HARLAN S Chief Scientific Officer Sale −17,329 $66.90 $1.2M 2,779
2021-01-21 ROBINS HARLAN S Chief Scientific Officer Sale −2,100 $67.59 $142K 679
2021-01-21 ROBINS HARLAN S Chief Scientific Officer Option exercise · Stock Option (Right to Buy) −23,370 210,330
2021-01-21 RUBINSTEIN JULIE President Option exercise +15,000 $6.32 $95K 15,000

Page 68 of 120 · 2,386 trades